Skip to main content
Contact Us
Subscribe
E-Edition
65°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Aclarion, Inc. - Common Stock
(NQ:
ACON
)
0.1740
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Aclarion, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st
November 14, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Friday's After-Market Session
October 11, 2024
Via
Benzinga
Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes
September 27, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Aclarion Provides Corporate Update on Nociscan AI Technology Milestones
September 12, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Aclarion, Inc.’s (NASDAQ: ACON) Emerging Role in the Back Pain Management Sector
September 11, 2024
Via
AB Newswire
ACON Stock Earnings: Aclarion Reported Results for Q1 2024
May 15, 2024
Aclarion just reported results for the first quarter of 2024.
Via
InvestorPlace
Aclarion, Inc.’s (NASDAQ: ACON) Emerging Role in the Back Pain Management Sector
September 11, 2024
Aclarion, Inc.’s (NASDAQ: ACON) Emerging Role in the Back Pain Management Sector
Via
News Direct
Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial
September 10, 2024
Initial LIFEHAB Enrolled Patients Receive Nociscan Exams to Help Evaluate How Biomarkers in the Discs of the Lumbar Spine Correspond With Treatment Response
Via
NewMediaWire
Aclarion Launches Surgeon Partnership to Apply Nociscan's AI Technology to Personal Injury and Workers Compensation Market
September 05, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey
August 29, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Micron To $140? Here Are 10 Top Analyst Forecasts For Monday
August 26, 2024
Via
Benzinga
Aclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan's AI Generated Biomarker Data Changes Surgical Treatment Plans
August 21, 2024
Via
NewMediaWire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Aclarion to Present at August 20th Virtual Investor Summit Microcap Event
August 15, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ACON Stock Earnings: Aclarion Beats EPS, Misses Revenue for Q2 2024
August 14, 2024
ACON stock results show that Aclarion beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Aclarion Announces First Commercial Agreement in Michigan
August 14, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Aclarion Hits Another Key Milestone by Adding Vitality - Third Major Payer to Cover Nociscan in Greater UK
August 13, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Aclarion Achieves Milestone With Key Second Payer Coverage of Nociscan by Aviva Throughout Greater London, UK
July 09, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Aclarion Announces Initial Payer Coverage of Nociscan by AXA Throughout Greater London, UK
June 26, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Aclarion Expands Commercial Engagement With The London Clinic to Grow Access to Nociscan Throughout Greater London
June 25, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Aclarion Receives Notice of Allowance for US Patent to Support Further Optimization of Accuracy and Reliability in the Nociscan Solution
June 20, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Intellectual Property
Exposures
Intellectual Property
Aclarion Receives Notice of Allowance for US Patent to Support Further Optimization of Accuracy and Reliability in the Nociscan Solution
June 20, 2024
Notice of Allowance is for the 23rd US Patent to be Awarded to Aclarion
Via
TheNewswire.com
Topics
Intellectual Property
Exposures
Intellectual Property
Aclarion Announces Updated Product Release That Enhances User-Experience, Scalability, and Security for Nociscan Solution
June 18, 2024
Nociscan is the first augmented intelligence platform to measure pain biomarkers in the lumbar spine.
Via
TheNewswire.com
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Aclarion Announces Updated Product Release That Enhances User-Experience, Scalability, and Security for Nociscan Solution
June 18, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
12 Health Care Stocks Moving In Friday's After-Market Session
May 17, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
April 26, 2024
Via
Benzinga
Why Alphabet Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
April 26, 2024
Via
Benzinga
Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
April 26, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
April 26, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
April 25, 2024
Via
Benzinga
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 25, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.